UBS Group AG

Position in INCR — Intercure Ltd.

CIK 1610520 ZURICH, V8

Position in INCR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$293

+$100 QoQ

Shares Held

267

+126.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#13

of 16 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. INCR ranks #76 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,643,241	$261,803,294
2	ELAN	Elanco Animal Health Inc	9,910,822	$243,905,327
3	UTHR	UNITED THERAPEUTICS Corp	220,616	$119,536,366
4	VTRS	Viatris Inc	6,092,296	$96,745,659
5	LNTH	Lantheus Holdings, Inc.	835,494	$92,689,703
6	HIMS	Hims & Hers Health, Inc.	2,660,810	$92,250,281
7	NBIX	Neurocrine Biosciences Inc	545,937	$92,012,220
8	TEVA	Teva Pharmaceutical Industries Ltd	2,140,065	$72,505,400

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$293	1,333	+125.5%	Shares	Defined	2026-08-13
2025-09-30	$193	591	-92.8%	Shares	Defined	2025-11-13
2025-06-30	$2,422	8,239	+18625.0%	Shares	Defined	2025-08-14
2024-09-30	$17	44	-99.0%	Shares	Sole	2024-11-14
2024-03-31	$2,443	4,508	-54.5%	Shares	Sole	2024-05-13
2023-12-31	$2,553	9,898	+1304.0%	Shares	Sole	2024-02-09
2023-09-30	$221	705	-58.5%	Shares	Sole	2023-11-09
2023-03-31	$692	1,698	-13.6%	Shares	Sole	2023-05-12
2022-12-31	$1,297	1,966	-69.0%	Shares	Sole	2023-02-08
2022-09-30	$5,702	6,337	+222.3%	Shares	Sole	2022-11-10
2022-06-30	$2,276	1,966	-81.0%	Shares	Sole	2022-08-10
2022-03-31	$14,727	10,372	-88.0%	Shares	Sole	2022-05-16
2021-12-31	$111,584	86,100	-24.6%	Shares	Sole	2022-02-14
2021-09-30	$158,308	114,220	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.